C. Pomȋrleanu

Practical Significance of Biomarkers in Axial Spondyloarthritis: Updates on Diagnosis, Disease Activity, and Prognosis

C. Lionte, L. Șorodoc, C. Ancuta, 2022, International journal of molecular sciences.

Where borders meet: Psoriasic arthritis and the cardiovascular risk

C. Pomîrleanu, C. Ancuța, Ana-Maria Doca, 2022, Romanian Journal of Rheumatology.

Autonomic Dysfunction and Cardiovascular Risk in Patients with Rheumatoid Arthritis: Can Heart Rate Variability Analysis Contribute to a Better Evaluation of the Cardiovascular Profile of a Patient?

C. Ancuta, A. Maștaleru, D. Cojocaru, 2023, Journal of clinical medicine.

BAFF System in Rheumatoid Arthritis: from Pathobiology to Therapeutic Targets

D. Opriș, C. Ancuta, C. Mihailov, 2017 .

A predictive model for remission and low disease activity in patients with established rheumatoid arthritis receiving TNF blockers

R. Chirieac, C. Ancuța, C. Pomîrleanu, 2013, Clinical Rheumatology.

Efficacy of baricitinib on periodontal inflammation in patients with rheumatoid arthritis.

R. Chirieac, E. Ancuța, C. Ancuța, 2020, Joint, bone, spine : revue du rhumatisme.